Related Experiment Video

Updated: Apr 29, 2026

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
06:42

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

2.9K

Antibiotic resistance in nosocomial respiratory infections

Gerald A Denys1, Ryan F Relich1

  • 1Division of Clinical Microbiology, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 350 West 11th Street, Room 6027B, Indianapolis, IN 46202, USA.

Clinics in Laboratory Medicine
|May 27, 2014
PubMed

Insights

Nosocomial respiratory infections, including hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), are common in critically ill patients. This review covers the causes, spread, and management of these infections linked to multidrug-resistant pathogens.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Nosocomial respiratory infections are prevalent in critically ill patients.
  • These infections contribute significantly to patient morbidity and mortality.
  • Multidrug-resistant (MDR) pathogens are key drivers of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).

Purpose of the Study:

  • To provide a comprehensive overview of HAP and VAP caused by antibiotic-resistant bacteria.
  • To detail the etiology, epidemiology, and pathogenesis of these infections.
  • To outline current diagnostic and treatment strategies for HAP and VAP due to MDR pathogens.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of etiological, epidemiological, and pathogenetic factors.
  • Review of diagnostic criteria and therapeutic guidelines.

Main Results:

  • MDR pathogens present a significant challenge in managing HAP and VAP.
  • Understanding pathogen characteristics is crucial for effective treatment.
  • Timely diagnosis and appropriate antimicrobial therapy are essential.

Conclusions:

  • Effective management of HAP and VAP requires a thorough understanding of MDR pathogens.
  • Integrated approaches to diagnosis and treatment are necessary.
  • Continued research is vital to combat the rising threat of antibiotic resistance in nosocomial infections.
Keywords:
Health care–associated infectionsHospital-acquired pneumoniaMultidrug resistant pathogensNosocomialVentilator-associated pneumonia

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

11.6K
Optical Screening of Novel Bacteria-specific Probes on Ex Vivo Human Lung Tissue by Confocal Laser Endomicroscopy09:24

Optical Screening of Novel Bacteria-specific Probes on Ex Vivo Human Lung Tissue by Confocal Laser Endomicroscopy

Published on: November 29, 2017

8.4K

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
215
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
55
Antibiotic Selection00:57

Antibiotic Selection

Overview
48.9K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
82